The demand for respiratory inhaler devices in uk is projected to grow from USD 3.7 billion in 2026 to USD 5.9 billion by 2036, at a CAGR of 4.7%. Dry Powder Inhalers will dominate with a 40.3% market share, while manually operated inhaler devices will lead the technology segment with a 72.5% share.